| scholarly article | Q13442814 |
| P50 | author | Jose Bolanos | Q90588795 |
| P2093 | author name string | Farid Saad | |
| Abraham Morgentaler | |||
| Abdulmaged Traish | |||
| Sunil Nair | |||
| P2860 | cites work | Testosterone replacement effectively inhibits the development of experimental autoimmune orchitis in rats: evidence for a direct role of testosterone on regulatory T cell expansion | Q43757090 |
| Bioavailable testosterone in men with rheumatoid arthritis-high frequency of hypogonadism | Q43948914 | ||
| Testosterone stimulates proliferation and inhibits interleukin-6 production of normal and hereditary gingival fibromatosis fibroblasts | Q44006234 | ||
| Prospective study of effect of androgens on serum inflammatory markers in men. | Q44063961 | ||
| Anti-androgen treatment of prostatic carcinoma may be a risk factor for development of rheumatoid arthritis | Q44204464 | ||
| Dehydroepiandrosterone therapy ameliorates experimental autoimmune myasthenia gravis in Lewis rats | Q44447763 | ||
| Less sensitivity for late airway inflammation in males than females in BALB/c mice | Q44468419 | ||
| Endocrinological disturbances in chronic obstructive pulmonary disease | Q44657673 | ||
| In vivo modulation of the circulating lymphocyte subsets and monocytes by androgen | Q44668258 | ||
| Farnesoid X receptor activation improves erectile function in animal models of metabolic syndrome and diabetes | Q44685906 | ||
| Androgens are protective in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. | Q44708828 | ||
| Androgen signaling negatively controls group 2 innate lymphoid cells | Q44943990 | ||
| The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. | Q44968760 | ||
| Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease | Q44991382 | ||
| Orchiectomy increases bone marrow interleukin-6 levels in mice | Q45110162 | ||
| Development of systemic lupus erythematosus in a male-to-female transsexual: the role of sex hormones revisited | Q45721965 | ||
| Epstein-Barr virus modulates 5-lipoxygenase product synthesis in human peripheral blood mononuclear cells | Q45764382 | ||
| Improvement of the metabolic syndrome and of non-alcoholic liver steatosis upon treatment of hypogonadal elderly men with parenteral testosterone undecanoate. | Q45995127 | ||
| Gonadal hormones in men with rheumatoid arthritis--from onset through 2 years | Q46094333 | ||
| Testosterone suppresses phospholipase D, causing sex differences in leukotriene biosynthesis in human monocytes | Q46262374 | ||
| Tumor necrosis factor-alpha inhibits endothelial nitric-oxide synthase gene promoter activity in bovine aortic endothelial cells | Q46419801 | ||
| Persistence of androgenic effects on the production of proinflammatory cytokines by circulating antigen-presenting cells after withdrawal of testosterone treatment in aging type 2 diabetic men with partial androgen deficiency | Q46423882 | ||
| The effects of short term (3 weeks) testosterone treatment on serum inflammatory markers in men undergoing coronary artery stenting | Q46615658 | ||
| Testosterone Supplementation during Respiratory Rehabilitation | Q46616187 | ||
| Endogenous progesterone and the exogenous progestin norethisterone enanthate are associated with a proinflammatory profile in healthy men. | Q46735528 | ||
| Influence of castration, alone or combined with thymectomy, on the development of diabetes in the nonobese diabetic mouse | Q46750416 | ||
| Testosterone patches in the management of patients with mild/moderate systemic lupus erythematosus | Q46780001 | ||
| Correlation between testosterone and the inflammatory marker soluble interleukin-6 receptor in older men. | Q46786642 | ||
| Oral testosterone supplementation and chronic low-grade inflammation in elderly men: a 26-week randomized, placebo-controlled trial | Q46884900 | ||
| Testosterone reduces macrophage expression in the mouse of toll-like receptor 4, a trigger for inflammation and innate immunity | Q46899768 | ||
| Testosterone Attenuates Group 2 Innate Lymphoid Cell-Mediated Airway Inflammation | Q47110409 | ||
| Testosterone Therapy and Glucose Homeostasis in Men with Testosterone Deficiency (Hypogonadism). | Q47302527 | ||
| Endotoxin initiated inflammation reduces testosterone production in men of reproductive age. | Q47355086 | ||
| Associations between clinically diagnosed testicular hypofunction and systemic lupus erythematosus: a record linkage study | Q47590435 | ||
| Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells | Q47802044 | ||
| Sex steroid hormones modulate the activation of murine peritoneal macrophages: receptor mediated modulation. | Q47822860 | ||
| Remission of Felty's Syndrome With Long-Term Testosterone Therapy | Q47961553 | ||
| Low testosterone levels and increased inflammatory markers in patients with cancer and relationship with cachexia | Q48713782 | ||
| FXR activation normalizes insulin sensitivity in visceral preadipocytes of a rabbit model of MetS. | Q50922510 | ||
| Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response. | Q50949591 | ||
| Attenuation of the September epidemic of asthma exacerbations in children: a randomized, controlled trial of montelukast added to usual therapy. | Q51105878 | ||
| Testosterone exerts selective anti-inflammatory effects on human skin mast cells in a cell subset dependent manner. | Q51295471 | ||
| Endogenous sex hormones and C-reactive protein in healthy Chinese men. | Q51361424 | ||
| Do low testosterone levels contribute to the pathogenesis of asthma? | Q51510437 | ||
| Androgens are bronchoactive drugs that act by relaxing airway smooth muscle and preventing bronchospasm. | Q51726839 | ||
| The evolution of vertebrate Toll-like receptors | Q24530086 | ||
| Th2 cytokines and asthma: an introduction | Q24791803 | ||
| High frequency of association of rheumatic/autoimmune diseases and untreated male hypogonadism with severe testicular dysfunction | Q24799929 | ||
| Sex hormone modulation of cell growth and apoptosis of the human monocytic/macrophage cell line | Q24812449 | ||
| Estradiol prevents and testosterone promotes Fas-dependent apoptosis in CD4+ Th2 cells by altering Bcl 2 expression | Q28371293 | ||
| The Nod-like receptor (NLR) family: a tale of similarities and differences | Q28472636 | ||
| Androgens alter T-cell immunity by inhibiting T-helper 1 differentiation | Q28655545 | ||
| Monocyte and macrophage heterogeneity | Q29547438 | ||
| Blood monocytes consist of two principal subsets with distinct migratory properties | Q29614286 | ||
| Origin and physiological roles of inflammation | Q29614298 | ||
| Testosterone therapy in men with Crohn's disease improves the clinical course of the disease: data from long-term observational registry study. | Q30960535 | ||
| Klinefelter's syndrome associated with systemic lupus erythematosus and autoimmune hepatitis | Q33372982 | ||
| Androgens as adjuvant treatment in postmenopausal female patients with rheumatoid arthritis | Q33579417 | ||
| Hormonal regulation of CD4(+) T-cell responses in coxsackievirus B3-induced myocarditis in mice | Q33813631 | ||
| Association of sex hormones and C-reactive protein levels in men | Q33835277 | ||
| Sex hormone adjuvant therapy in rheumatoid arthritis | Q34085910 | ||
| Skin immune sentinels in health and disease | Q34165173 | ||
| Sex hormone modulation of proinflammatory cytokine and C-reactive protein expression in macrophages from older men and postmenopausal women | Q34196350 | ||
| The relationship between level of androgenic hormones and coronary artery disease in men. | Q34221162 | ||
| The role of TLR2 in the host response to pneumococcal pneumonia in absence of the spleen | Q34313005 | ||
| Clinical use of anti-TNF therapy and increased risk of infections | Q34338096 | ||
| Mast cell function: a new vision of an old cell | Q34430917 | ||
| Androgen-replacement therapy depresses the ex vivo production of inflammatory cytokines by circulating antigen-presenting cells in aging type-2 diabetic men with partial androgen deficiency | Q34531591 | ||
| Estrogen and testosterone therapies in multiple sclerosis | Q34610594 | ||
| Testosterone treatment in multiple sclerosis: a pilot study | Q34628272 | ||
| Ulcerative colitis and colorectal cancer. A population-based study | Q34634203 | ||
| Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis | Q34735562 | ||
| Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study | Q34804834 | ||
| Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review | Q34812877 | ||
| Endogenous testosterone level and testosterone supplementation therapy in chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis. | Q34940755 | ||
| Perimenstrual asthma: a syndrome without known cause or cure | Q35191471 | ||
| Chronic testosterone replacement exerts cardioprotection against cardiac ischemia-reperfusion injury by attenuating mitochondrial dysfunction in testosterone-deprived rats | Q35231463 | ||
| Rheumatoid arthritis. I. Clinical effects of testosterone and pregnenolone therapy | Q35678657 | ||
| Testosterone regulates bone response to inflammation. | Q35910549 | ||
| Androgen receptor influences on body defense system via modulation of innate and adaptive immune systems: lessons from conditional AR knockout mice | Q36355602 | ||
| Insulin Resistance and Inflammation in Hypogonadotropic Hypogonadism and Their Reduction After Testosterone Replacement in Men With Type 2 Diabetes | Q36392574 | ||
| Testosterone replacement therapy for the treatment of neurological and neuropsychiatric disorders | Q36547448 | ||
| Therapeutic testosterone administration preserves excitatory synaptic transmission in the hippocampus during autoimmune demyelinating disease | Q36608070 | ||
| Differential Th1 and Th2 cell responses in male and female BALB/c mice infected with coxsackievirus group B type 3 | Q36625352 | ||
| Are there reasons why adult asthma is more common in females? | Q36793287 | ||
| Immune modulation and increased neurotrophic factor production in multiple sclerosis patients treated with testosterone | Q36841506 | ||
| Role of androgens in dhea-induced rack1 expression and cytokine modulation in monocytes. | Q36945783 | ||
| ERK-mediated regulation of leukotriene biosynthesis by androgens: a molecular basis for gender differences in inflammation and asthma | Q37003847 | ||
| Testosterone alleviates tumor necrosis factor-alpha-mediated tissue factor pathway inhibitor downregulation via suppression of nuclear factor-kappa B in endothelial cells | Q37074249 | ||
| Susceptibility to autoimmunity and B cell resistance to apoptosis in mice lacking androgen receptor in B cells | Q37155385 | ||
| Association between endogenous sex steroid hormones and inflammatory biomarkers in US men | Q37265941 | ||
| Neutropenia with impaired host defense against microbial infection in mice lacking androgen receptor | Q37273091 | ||
| Harmful molecular mechanisms in sepsis | Q37273299 | ||
| Testosterone and coronary artery disease | Q37326212 | ||
| Sex steroids as inflammatory regulators | Q37666220 | ||
| Androgens and chronic obstructive pulmonary disease | Q37685980 | ||
| Metabolic endotoxaemia related inflammation is associated with hypogonadism in overweight men | Q37686341 | ||
| Emerging role for TNF-α in erectile dysfunction | Q37719686 | ||
| The role of inflammation in the pathogenesis of non-small cell lung cancer | Q37820631 | ||
| Should androgenic anabolic steroids be considered in the treatment regime of selected chronic obstructive pulmonary disease patients? | Q37970575 | ||
| Cardiovascular risk and psoriasis: beyond the traditional risk factors | Q38155667 | ||
| The immunopathogenesis of psoriasis | Q38269968 | ||
| Key participants of the tumor microenvironment of the prostate: an approach of the structural dynamic of cellular elements and extracellular matrix components during epithelial-stromal transition. | Q38281640 | ||
| Inhibition of interleukin-17, interleukin-23 and the TH17 cell pathway in the treatment of psoriatic arthritis and psoriasis | Q38323060 | ||
| Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial | Q38601785 | ||
| Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease | Q38606033 | ||
| Leukotriene C4 Potentiates IL-33-Induced Group 2 Innate Lymphoid Cell Activation and Lung Inflammation | Q38699307 | ||
| 6-O-Veratroyl catalpol suppresses pro-inflammatory cytokines via regulation of extracellular signal-regulated kinase and nuclear factor-κB in human monocytic cells | Q38828932 | ||
| Long-Term Testosterone Therapy Improves Cardiometabolic Function and Reduces Risk of Cardiovascular Disease in Men with Hypogonadism: A Real-Life Observational Registry Study Setting Comparing Treated and Untreated (Control) Groups | Q38830965 | ||
| Hypogonadism and the risk of rheumatic autoimmune disease. | Q38850495 | ||
| Anti-inflammation effect of methyl salicylate 2-O-β-D-lactoside on adjuvant induced-arthritis rats and lipopolysaccharide (LPS)-treated murine macrophages RAW264.7 cells. | Q38914711 | ||
| Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation | Q39160111 | ||
| Low testosterone elevates interleukin family cytokines in a rodent model: a possible mechanism for the potentiation of vascular disease in androgen-deficient males | Q39215600 | ||
| Efficacy and Safety Profile of Anti-tumor Necrosis Factor-α Versus Anti-integrin Agents for the Treatment of Crohn's Disease: A Network Meta-analysis of Indirect Comparisons | Q39841012 | ||
| Sex hormones modulate the effects of Leflunomide on cytokine production by cultures of differentiated monocyte/macrophages and synovial macrophages from rheumatoid arthritis patients | Q39867746 | ||
| Treatment of Rheumatoid Arthritis With Anti-Tumor Necrosis Factor or Tocilizumab Therapy as First Biologic Agent in a Global Comparative Observational Study | Q40169531 | ||
| Association of Testosterone Replacement With Cardiovascular Outcomes Among Men With Androgen Deficiency | Q40316690 | ||
| Dihydrotestosterone decreases tumor necrosis factor-alpha and lipopolysaccharide-induced inflammatory response in human endothelial cells. | Q40346017 | ||
| Testosterone inhibits expression of inducible nitric oxide synthase in murine macrophages | Q40824890 | ||
| Testosterone and Cardiovascular Disease | Q40929054 | ||
| Sex hormones modulate inflammatory mediators produced by macrophages | Q40940462 | ||
| Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells. | Q40981150 | ||
| Curcumin suppresses NLRP3 inflammasome activation and protects against LPS-induced septic shock. | Q41065254 | ||
| Neuroprotective effects of an aqueous extract of Futokadsura stem in an Aβ-induced Alzheimer's disease-like rat model | Q41095599 | ||
| Inhibition of NFkappaB activity through maintenance of IkappaBalpha levels contributes to dihydrotestosterone-mediated repression of the interleukin-6 promoter | Q41157776 | ||
| Free and serum testosterone levels in 276 males: a comparative study of rheumatoid arthritis, ankylosing spondylitis and healthy controls | Q41325967 | ||
| Remission of type 2 diabetes in a hypogonadal man under long-term testosterone therapy | Q41405214 | ||
| Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men. | Q41507830 | ||
| Testosterone therapy and risk of myocardial infarction: a pharmacoepidemiologic study | Q41591016 | ||
| Study of androgen and atherosclerosis in old-age male | Q42151460 | ||
| Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life | Q42483273 | ||
| Role of testosterone in regulating induction of TNF-α in rat spleen via ERK signaling pathway | Q42490744 | ||
| Testosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbit | Q42725858 | ||
| Androgen-androgen receptor system improves chronic inflammatory conditions by suppressing monocyte chemoattractant protein-1 gene expression in adipocytes via transcriptional regulation | Q42809132 | ||
| Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study | Q42934081 | ||
| The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits tumor necrosis factor alpha and lipopolysaccharide induced inflammatory response in human endothelial cells and in mice aorta | Q43014669 | ||
| Elevated high sensitivity C-reactive protein levels in aging men with low testosterone | Q43225768 | ||
| Human mast cells express androgen receptors but treatment with testosterone exerts no influence on IgE-independent mast cell degranulation elicited by neuromuscular blocking agents | Q43275830 | ||
| Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome | Q43280669 | ||
| Endogenous and exogenous sex steroid hormones and asthma and wheeze in young women | Q43441571 | ||
| Testosterone acts directly on CD4+ T lymphocytes to increase IL-10 production | Q43699058 | ||
| Anti-TNF and sex hormones. | Q51794976 | ||
| Effect of fetal sex on airway lability in pregnant women with asthma. | Q51827991 | ||
| Hypogonadal men with psoriasis benefit from long-term testosterone replacement therapy - a series of 15 case reports. | Q52864351 | ||
| Impact of Testosterone Replacement Therapy on Myocardial Infarction, Stroke, and Death in Men With Low Testosterone Concentrations in an Integrated Health Care System. | Q53211173 | ||
| The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes. | Q53820607 | ||
| Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy. | Q54138868 | ||
| Toll-like receptor 4 in rat prostate: modulation by testosterone and acute bacterial infection in epithelial and stromal cells. | Q54458870 | ||
| Testosterone replacement therapy in hypogonadal men is associated with increased expression of LAMP-2 (CD107b) by circulating monocytes and dendritic cells. | Q54792823 | ||
| Androgen-Induced Immunosuppression. | Q55357541 | ||
| Psoriasis | Q56115292 | ||
| Testosterone replacement therapy and hospitalization rates in men with COPD | Q57158313 | ||
| Defining the Origins of the NOD-Like Receptor System at the Base of Animal Evolution | Q57244547 | ||
| The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes | Q58308801 | ||
| Influence of Testosterone Therapy on Clinical and Immunological Features of Autoimmune Diseases Associated with Klinefelter’s Syndrome | Q61628573 | ||
| Testosterone treatment improves metabolic syndrome-induced adipose tissue derangements | Q61971011 | ||
| Type 2 Diabetes and Testosterone Therapy. | Q64898248 | ||
| Potential application of testosterone replacement therapy as treatment for obesity and type 2 diabetes in men. | Q64998864 | ||
| Androgen replacement therapy in male patients with rheumatoid arthritis | Q67897215 | ||
| The serum testosterone level of patients with bronchial asthma treated with corticosteroids and untreated | Q68008674 | ||
| Sex hormone status of male patients with rheumatoid arthritis: evidence of low serum concentrations of testosterone at baseline and after human chorionic gonadotropin stimulation | Q70407740 | ||
| Priming of human peripheral blood mononuclear cells with lipopolysaccharides for enhanced arachidonic acid release and leukotriene synthesis | Q71131924 | ||
| Serum testosterone depression associated with hypoxia in respiratory failure | Q71138609 | ||
| A randomized trial of testosterone therapy in males with rheumatoid arthritis | Q71160663 | ||
| Case report: testosterone treatment of systemic lupus erythematosus in a patient with Klinefelter's syndrome | Q71775411 | ||
| Testosterone inhibits immunoglobulin production by human peripheral blood mononuclear cells | Q71778779 | ||
| Steroid sex hormones regulate the release of tumor necrosis factor by macrophages | Q72503722 | ||
| Effects of sex hormones on production of prostaglandin E2 by human peripheral monocytes | Q72742448 | ||
| Failure of androgen therapy in a flare-up of acute disseminated lupus erythematosus | Q72790767 | ||
| Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus | Q73766197 | ||
| Androgens alter B cell development in normal male mice | Q74352464 | ||
| Lupus erythematosus, chronic disseminated type, showing a dramatic response to testosterone therapy | Q76032749 | ||
| Inverse relationship between serum levels of interleukin-1beta and testosterone in men with stable coronary artery disease | Q80393701 | ||
| Physiological testosterone stimulates tissue plasminogen activator and tissue factor pathway inhibitor and inhibits plasminogen activator inhibitor type 1 release in endothelial cells | Q80395955 | ||
| High prevalence of androgen deficiency and abnormal lipid profile in infertile men with non-obstructive azoospermia | Q83942958 | ||
| Effects of testosterone, estrogen and progesterone on TNF-α mediated cellular damage in rat arthritic synovial fibroblasts | Q85018019 | ||
| [Chronic obstructive pulmonary disease: risk and benefit of testosterone therapy] | Q85652670 | ||
| Testosterone and high-sensitive C-reactive protein in coronary artery disease patients awaiting coronary artery bypass graft | Q87841453 | ||
| Testosterone and estrogen in multiple sclerosis: from pathophysiology to therapeutics | Q88810744 | ||
| Therapeutic drug monitoring of tumour necrosis factor inhibitors in the management of chronic inflammatory diseases | Q88883428 | ||
| Real-World Outcomes of Vedolizumab Therapy in Ulcerative Colitis and Crohn's Disease at a Tertiary Referral Center | Q91082312 | ||
| Effect of testosterone replacement therapy on sexual function and glycemic control among hypogonadal men with type 2 diabetes mellitus | Q91090913 | ||
| Long-term testosterone therapy in type 2 diabetes is associated with reduced mortality without improvement in conventional cardiovascular risk factors | Q91450345 | ||
| Localization of androgen receptor expression in human bone marrow | Q95720991 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pathophysiology | Q1135939 |
| P304 | page(s) | 549 | |
| P577 | publication date | 2018-12-14 | |
| P1433 | published in | Journal of Clinical Medicine | Q27724774 |
| P1476 | title | Do Androgens Modulate the Pathophysiological Pathways of Inflammation? Appraising the Contemporary Evidence | |
| P478 | volume | 7 |
| Q64110519 | A Randomized, Double-Blind, Placebo-Controlled, Crossover Study Examining the Hormonal and Vitality Effects of Ashwagandha (Withania somnifera) in Aging, Overweight Males |
| Q89976009 | Effect of DHT-Induced Hyperandrogenism on the Pro-Inflammatory Cytokines in a Rat Model of Polycystic Ovary Morphology |
| Q90108558 | Frailty syndrome is associated with changes in peripheral inflammatory markers in prostate cancer patients undergoing androgen deprivation therapy |
| Q92330824 | Incidence of invasive breast cancer in women treated with testosterone implants: a prospective 10-year cohort study |
| Q89629637 | Sex effects in pyelonephritis |
| Q100428152 | Sex steroids and autoimmune rheumatic diseases: state of the art |
Search more.